Andreas Kateifides, MD
Research Scientist (previously held)
Boston University Medical Campus
Cardiovascular Institute (Whitaker)



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Pérez Valdivia MÁ, Wu MS, Susan Huang SH, Alamartine E, Kim SG, Yee M, Kateifides A, Rice K, Garlo K, Barratt J. Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial. J Am Soc Nephrol. 2024 Oct 25. PMID: 39455063
     
  2. Fotakis P, Tiniakou I, Kateifides AK, Gkolfinopoulou C, Chroni A, Stratikos E, Zannis VI, Kardassis D. Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL. J Lipid Res. 2013 Dec; 54(12):3293-302.View Related Profiles. PMID: 24123812; PMCID: PMC3826677; DOI: 10.1194/jlr.M043489;
     
  3. Fotakis P, Kateifides AK, Gkolfinopoulou C, Georgiadou D, Beck M, Gründler K, Chroni A, Stratikos E, Kardassis D, Zannis VI. Role of the hydrophobic and charged residues in the 218-226 region of apoA-I in the biogenesis of HDL. J Lipid Res. 2013 Dec; 54(12):3281-92.View Related Profiles. PMID: 23990662; PMCID: PMC3826676; DOI: 10.1194/jlr.M038356;
     
  4. Duka A, Fotakis P, Georgiadou D, Kateifides A, Tzavlaki K, von Eckardstein L, Stratikos E, Kardassis D, Zannis VI. ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT. J Lipid Res. 2013 Jan; 54(1):107-15.View Related Profiles. PMID: 23132909; PMCID: PMC3520517; DOI: 10.1194/jlr.M030114;
     
  5. Biedzka-Sarek M, Metso J, Kateifides A, Meri T, Jokiranta TS, Muszynski A, Radziejewska-Lebrecht J, Zannis V, Skurnik M, Jauhiainen M. Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3. J Biol Chem. 2011 Nov 4; 286(44):38211-9.View Related Profiles. PMID: 21896489; PMCID: PMC3207405; DOI: 10.1074/jbc.M111.249482;
     
  6. Haase CL, Frikke-Schmidt R, Nordestgaard BG, Kateifides AK, Kardassis D, Nielsen LB, Andersen CB, Køber L, Johnsen AH, Grande P, Zannis VI, Tybjaerg-Hansen A. Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels. J Intern Med. 2011 Aug; 270(2):136-46.View Related Profiles. PMID: 21443680; DOI: 10.1111/j.1365-2796.2011.02381.x;
     
  7. Kateifides AK, Gorshkova IN, Duka A, Chroni A, Kardassis D, Zannis VI. Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL. J Lipid Res. 2011 Jul; 52(7):1363-72.View Related Profiles. PMID: 21504968; PMCID: PMC3122915; DOI: 10.1194/jlr.M012989;
     
  8. Ohnsorg PM, Rohrer L, Perisa D, Kateifides A, Chroni A, Kardassis D, Zannis VI, von Eckardstein A. Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells. J Biol Chem. 2011 Mar 11; 286(10):7744-54.View Related Profiles. PMID: 21209084; PMCID: PMC3048662; DOI: 10.1074/jbc.M110.193524;
     
  9. Samonis G, Maraki S, Leventakos K, Spanaki AM, Kateifidis A, Galanakis E, Tselentis Y, Falagas ME, Mantadakis E. Comparative effects of ertapenem, imipenem, and meropenem on the colonization of the gastrointestinal tract of mice by Candida albicans. Med Mycol. 2006 May; 44(3):233-5. PMID: 16702102
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 9 publications over 5 distinct years, with a maximum of 4 publications in 2011

YearPublications
20061
20114
20121
20132
20241

Contact for Mentoring:

700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map


Kateifides's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department